Drivers and barriers of vaccine acceptance among pregnant women in Kenya.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
02 10 2020
Historique:
pubmed: 27 3 2020
medline: 22 6 2021
entrez: 27 3 2020
Statut: ppublish

Résumé

Maternal vaccination coverage remains suboptimal globally and is lowest in low- and middle-income countries. Attitudes toward maternal vaccines have been characterized in middle-high income settings, however data from African countries are limited. We assessed drivers and barriers of vaccine acceptance among pregnant women in Kenya. We conducted a cross-sectional survey among pregnant women aged 15-49 y. We enrolled a convenience sample of women presenting for antenatal care at seven health-care facilities in four diverse counties (Nairobi, Mombasa, Marsabit, Siaya) of Kenya and from the community in two counties (Nairobi, Siaya). We described frequencies of socio-demographic characteristics of participants and their knowledge, attitudes, and beliefs regarding maternal vaccination. We enrolled 604 pregnant women with a median age of 26.5 y, of whom 48.2% had primary education or less. More than 95% agreed that maternal vaccines are "important for my health" and that getting vaccinated is "a good way to protect myself from disease". The most commonly cited reason in favor of maternal vaccination was disease prevention (53.2%). Fear of side effects to mother/baby (15.1%) was the most frequently reported potential barrier. Influenza vaccine is not in routine use in Kenya; however, 77.8% reported willingness to accept influenza vaccination during pregnancy. Maternal vaccination is well accepted among Kenyan pregnant women. We identified the provision of adequate vaccine information and addressing safety concerns as opportunities to improve maternal vaccine uptake. The expressed willingness to receive a vaccine not currently in routine use bodes well for implementation of new maternal vaccines in Kenya.

Identifiants

pubmed: 32208952
doi: 10.1080/21645515.2020.1723364
pmc: PMC7644175
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2429-2437

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Références

Wkly Epidemiol Rec. 2015 Aug 28;90(35):433-58
pubmed: 26320265
Lancet. 2011 Aug 6;378(9790):526-35
pubmed: 21664679
Vaccine. 2019 Nov 28;37(50):7394-7395
pubmed: 29395536
PLoS One. 2018 Jun 14;13(6):e0197867
pubmed: 29902184
Curr Opin Infect Dis. 2015 Jun;28(3):221-4
pubmed: 25918956
Vaccine. 2015 Nov 25;33(47):6372-3
pubmed: 26263199
Hum Vaccin Immunother. 2019;15(2):283-286
pubmed: 30252609
Vaccine. 2017 Oct 27;35(45):6059-6069
pubmed: 28974409
Wkly Epidemiol Rec. 2012 Nov 23;87(47):461-76
pubmed: 23210147
Hum Vaccin Immunother. 2016 Apr 2;12(4):857-65
pubmed: 26552807
Vaccine. 2014 Feb 7;32(7):785-92
pubmed: 24394441
Vaccine. 2011 Mar 3;29(11):2024-8
pubmed: 21272604
Vaccine. 2013 Aug 28;31 Suppl 4:D52-7
pubmed: 23973347
Pan Afr Med J. 2017 Jun 22;27(Suppl 3):24
pubmed: 29296159
J Health Commun. 2011 Mar;16(3):227-9
pubmed: 21391044
Bull World Health Organ. 2012 Nov 1;90(11):822-30
pubmed: 23226894
Vaccine. 2019 Jan 14;37(3):464-472
pubmed: 30502070
Vaccine. 2017 Sep 25;35(40):5352-5359
pubmed: 28863869
Vaccine. 2012 Jun 13;30(28):4200-8
pubmed: 22537991
BMC Int Health Hum Rights. 2018 Jun 28;18(1):27
pubmed: 29950171
Vaccine. 2014 Apr 17;32(19):2150-9
pubmed: 24598724
Vaccine. 2015 Aug 14;33(34):4165-75
pubmed: 25896384
Lancet Infect Dis. 2017 Jul;17(7):e197-e208
pubmed: 28433705
Vaccine. 2017 Aug 16;35(35 Pt A):4457-4460
pubmed: 28237500
Vaccine. 2015 Nov 25;33(47):6420-9
pubmed: 26320417
J Prim Health Care. 2018 Mar;10(1):62-67
pubmed: 30068453
Adv Prev Med. 2012;2012:932741
pubmed: 23082253
Pan Afr Med J. 2017 Jun 22;27(Suppl 3):25
pubmed: 29296160
Curr Opin Pediatr. 2017 Dec;29(6):737-743
pubmed: 28922318
Vaccine. 2015 Jun 12;33(26):2971-7
pubmed: 25936666

Auteurs

Nancy A Otieno (NA)

Center for Global Health Research, Kenya Medical Research Institute , Kisumu, Kenya.

Fredrick Otiato (F)

Center for Global Health Research, Kenya Medical Research Institute , Kisumu, Kenya.

Bryan Nyawanda (B)

Center for Global Health Research, Kenya Medical Research Institute , Kisumu, Kenya.

Maxwel Adero (M)

Center for Global Health Research, Kenya Medical Research Institute , Kisumu, Kenya.

Winnie N Wairimu (WN)

Center for Global Health Research, Kenya Medical Research Institute , Kisumu, Kenya.

Dominic Ouma (D)

Center for Global Health Research, Kenya Medical Research Institute , Kisumu, Kenya.

Raphael Atito (R)

Center for Global Health Research, Kenya Medical Research Institute , Kisumu, Kenya.

Andrew Wilson (A)

Rollins School of Public Health, Hubert Department of Global Health, Emory University , Atlanta, GA, USA.

Ines Gonzalez-Casanova (I)

Rollins School of Public Health, Hubert Department of Global Health, Emory University , Atlanta, GA, USA.

Fauzia A Malik (FA)

Rollins School of Public Health, Hubert Department of Global Health, Emory University , Atlanta, GA, USA.

Marc-Alain Widdowson (MA)

Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention , Nairobi, Kenya.
Institute of Tropical Medicine , Antwerp.

Saad B Omer (SB)

Yale Institute for Global Health.
Department of Internal Medicine (Infectious Diseases), Yale School of Medicine.
Department of Epidemiology of Microbial Diseases, Yale School of Public Health.

Sandra S Chaves (SS)

Influenza Program, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Nairobi, Kenya.

Jennifer R Verani (JR)

Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention , Nairobi, Kenya.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH